CYTOKINE DESIGNATED LERK-8

(19)

(11)

EP 0 904 287 A2

(12)

(43)	Date of publication:
	31.03.1999 Bulletin 1999/13

(21)	Application number: 97916886.0

(22)	Date of filing: 19.03.1997

(51)

International Patent Classification (IPC):

C12N 15/ 09^{( . )}
A61K 39/ 395^{( . )}
A61P 9/ 10^{( . )}
A61P 25/ 14^{( . )}
A61P 25/ 28^{( . )}
C07K 14/ 47^{( . )}
C07K 16/ 24^{( . )}
C12N 1/ 19^{( . )}
C12N 5/ 10^{( . )}
C12P 21/ 08^{( . )}

A61K 38/ 00^{( . )}
A61P 9/ 00^{( . )}
A61P 25/ 08^{( . )}
A61P 25/ 16^{( . )}
A61P 43/ 00^{( . )}
C07K 14/ 52^{( . )}
C12N 1/ 15^{( . )}
C12N 1/ 21^{( . )}
C12P 21/ 02^{( . )}

(86)	International application number:
	PCT/US1997/004533

(87)	International publication number:
	WO 1997/036919 (09.10.1997 Gazette 1997/43)

(84)	Designated Contracting States:
	AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30)

Priority:

21.03.1996 US 19960621146

(71)	Applicant: IMMUNEX CORPORATION
	Seattle Washington 98101 (US)

(72)	Inventor:
	CERRETTI, Douglas, P. Seattle, WA 98133 (US)

(74)	Representative: Sheard, Andrew Gregory
	Kilburn & Strode 20 Red Lion Street London WC1R 4PJ London WC1R 4PJ (GB)

(54)	CYTOKINE DESIGNATED LERK-8